OncoGenex develops and commercializes innovative therapies for the treatment of a variety of cancers.
OncoGenex’ mission is to meet the challenge of treatment resistance through the development and commercialization of first-in-class, innovative therapies that have the potential to redefine treatment outcomes for patients with a variety of cancers.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Oct 29, 2003 | Post-IPO Equity | $11.50M | 1 | Working Opportunity Fund | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Working Opportunity Fund | Yes | Post-IPO Equity |